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Cochlospermum ango/ensisWelw. (borututu) is widespread in parts of Angola, as the name 
indicates, and belongs to the Cochlospermaceae family. Its bark infusion is used in the traditional 
medicine of Angola for the treatment of hepatic diseases and for the prophylaxis of malaria (1 ,2]. 
In the present work, the infusion and dietary supplements of borututu, widely used for their 
hepatoprotective effects, were submitted to an evaluation of bioactive compounds (phenolics and 
flavonoids), antioxidant activity (expressed as DPPH scavenging activity, reducing power, 13-
carotene bleaching inhibition, and TBARS formation inhibition), anti- hepatocellular carcinoma 
activity (HepG2 tumour cell line) and hepatotoxicity (non-tumour liver primary culture PLP2). 
Borututu infusion gave high amounts of total phenolics ( 132.26 mg of gallic acid equivalents/g) 
and flavonoids (17.88 mg of catechin equivalents/g), as also high antioxidant activity (EC50 s 170 
119/ml) in all the assays and also revealed anti-hepatocellular carcinoma activity (GI50 = 146 
119/ml) without toxicity for non-tumour liver cells (GI50> 400 11g/ml). The bioactive properties 
(antioxidant and antitumour) of the infusion were positively correlated with phenolics and 
flavonoids content. This plant revealed antioxidant properties with EC50 values lower than the daily 
recommended dose, but infusion was more active than dietary supplements. Moreover, dietary 
supplements, up to 400 11g/ml, did not inhibit the growth of hepatocellular carcinoma cell line 
(HepG2). 
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